Joshua Sill, Benjamin Chilampath, Matthew Bernens, Patricia Banks, Samuel Stein
{"title":"评估并改进成人囊性纤维化诊所人群中与服用 elexacaftor/tezacaftor/ivacaftor 相关的患者知识差距","authors":"Joshua Sill, Benjamin Chilampath, Matthew Bernens, Patricia Banks, Samuel Stein","doi":"10.1183/23120541.acf-2023.43","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":505181,"journal":{"name":"Adult Cystic Fibrosis","volume":"49 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Assessing and improving patient knowledge gaps relating to the administration of elexacaftor/tezacaftor/ivacaftor in an adult cystic fibrosis clinic population\",\"authors\":\"Joshua Sill, Benjamin Chilampath, Matthew Bernens, Patricia Banks, Samuel Stein\",\"doi\":\"10.1183/23120541.acf-2023.43\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":505181,\"journal\":{\"name\":\"Adult Cystic Fibrosis\",\"volume\":\"49 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Adult Cystic Fibrosis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1183/23120541.acf-2023.43\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Adult Cystic Fibrosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/23120541.acf-2023.43","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Assessing and improving patient knowledge gaps relating to the administration of elexacaftor/tezacaftor/ivacaftor in an adult cystic fibrosis clinic population